insider24.ch
Back to the feed

Shareholding disclosure

Aisling Capital Partners III, LLC

inKuros Biosciences AG

Declared position

8.76%

Threshold

Crossed upwards

Timeline

Published

05.02.2015

Transaction

30.01.2015

Voting rights breakdown

Voting rights acquired8.76%
Voting rights sold0%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAF2400014

Beneficial owner

Aisling Capital Partners III, LLC

Declared address

Aisling Capital Partners III, LLC, 10106 New York

Expiry of the conversion rights under the convertible loan notes. Warrants are directly held by Aisling Capital III, LP, 888 Seventh Avenue, New York, NY 10106, USA, whose general partner is Aisling Capital Partners III, LP, 888 Seventh Avenue, New York, NY 10106, USA. The general partner of Aisling Capital Partners III, LP, 888 Seventh Avenue, New York, NY 10106, USA, is Aisling Capital Partners III, LLC, 888 Seventh Avenue, New York, NY 10106, USA. Aisling Investors III, LP, 888 Seventh Avenue, New York, NY 10106, USA, is an affiliated limited partner. Aisling Capital, LLC, 888 Seventh Avenue, New York, NY 10106, USA, is the investment manager.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open